| （単位：千ドル） | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 4,817 | 7,265 | 9,787 | 10,945 | 13,887 | 13,070 | 11,706 | 9,583 | 10,838 | 12,908 | 15,271 | 12,528 | 13,120 |
| 営業費用 | 7,452 | 10,956 | 13,795 | 15,366 | 19,120 | 17,509 | 16,687 | 14,148 | 15,148 | 17,904 | 20,103 | 17,124 | 17,991 |
| 営業利益 | -7,452 | -10,956 | -13,795 | -15,366 | -14,972 | -12,539 | -12,223 | -6,067 | -9,251 | -17,162 | -18,960 | -17,124 | -17,991 |
| 純利益 | -7,435 | -10,921 | -13,758 | -15,343 | -14,594 | -11,943 | -11,982 | -5,098 | -8,285 | -16,193 | -17,249 | -16,673 | -18,089 |
| 一株あたり利益 | -83.36 | -3.82 | -0.51 | -0.56 | -0.53 | -0.4 | -0.34 | -0.14 | -0.23 | -0.39 | -0.4 | -0.38 | -0.4 |
| 希薄化後一株あたり利益 | -83.36 | -3.82 | -0.51 | -0.56 | -0.53 | -0.4 | -0.34 | -0.14 | -0.23 | -0.39 | -0.43 | -0.38 | -0.4 |